Hung Lab

By using small organic molecules and applying systematic genetic perturbations, the lab hopes to gain new insight into bacterial responses to host immunity and chemotherapy and to establish new therapeutic paradigms for a variety of devastating pathogens, including Klebsiella pneumoniae, Pseudomonas aeruginosa and Mycobacterium tuberculosis.

Primary Investigators

Core Member and Co-Director of the Infectious Disease and Microbiome Program at the Broad Institute of MIT and Harvard

Professor in the Department of Genetics at Harvard Medical School

Professor in the Department of Molecular Biology at Massachusetts General Hospital


Primary contacts

Marissa Jenko, Administrative Assistant